These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 19523171)
1. CDKN2A mutations in melanoma families from Uruguay. Larre Borges A; Cuéllar F; Puig-Butillé JA; Scarone M; Delgado L; Badenas C; Milà M; Malvehy J; Barquet V; Núñez J; Laporte M; Fernández G; Levrero P; Martínez-Asuaga M; Puig S Br J Dermatol; 2009 Sep; 161(3):536-41. PubMed ID: 19523171 [TBL] [Abstract][Full Text] [Related]
2. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation. Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834 [TBL] [Abstract][Full Text] [Related]
3. High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families. Mantelli M; Barile M; Ciotti P; Ghiorzo P; Lantieri F; Pastorino L; Catricalà C; Torre GD; Folco U; Grammatico P; Padovani L; Pasini B; Rovini D; Queirolo P; Rainero ML; Santi PL; Sertoli RM; Goldstein AM; Bianchi-Scarrà G; ; Am J Med Genet; 2002 Jan; 107(3):214-21. PubMed ID: 11807902 [TBL] [Abstract][Full Text] [Related]
4. Alterations in CDKN2A locus as potential indicator of melanoma predisposition in relatives of non-familial melanoma cases. Levanat S; Situm M; Crnić I; Marasović D; Puizina-Ivić N; Pokupcić N; Musani V; Komar A; Kubat M; Furac I; Karija-Vlahović M; Krizanac S Croat Med J; 2003 Aug; 44(4):418-24. PubMed ID: 12950144 [TBL] [Abstract][Full Text] [Related]
5. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas. Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381 [TBL] [Abstract][Full Text] [Related]
6. Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families. Yakobson E; Shemesh P; Azizi E; Winkler E; Lassam N; Hogg D; Brookes S; Peters G; Lotem M; Zlotogorski A; Landau M; Safro M; Shafir R; Friedman E; Peretz H Eur J Hum Genet; 2000 Aug; 8(8):590-6. PubMed ID: 10951521 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds. Flores JF; Pollock PM; Walker GJ; Glendening JM; Lin AH; Palmer JM; Walters MK; Hayward NK; Fountain JW Oncogene; 1997 Dec; 15(24):2999-3005. PubMed ID: 9416844 [TBL] [Abstract][Full Text] [Related]
8. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma. Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families. Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811 [TBL] [Abstract][Full Text] [Related]
10. CDKN2A mutations in Scottish families with cutaneous melanoma: results from 32 newly identified families. Lang J; Boxer M; MacKie RM Br J Dermatol; 2005 Dec; 153(6):1121-5. PubMed ID: 16307646 [TBL] [Abstract][Full Text] [Related]
11. A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families. Yakobson E; Eisenberg S; Isacson R; Halle D; Levy-Lahad E; Catane R; Safro M; Sobolev V; Huot T; Peters G; Ruiz A; Malvehy J; Puig S; Chompret A; Avril MF; Shafir R; Peretz H; Bressac-de Paillerets B Eur J Hum Genet; 2003 Apr; 11(4):288-96. PubMed ID: 12700603 [TBL] [Abstract][Full Text] [Related]
12. CDKN2A as a uveal and cutaneous melanoma susceptibility gene. Kannengiesser C; Avril MF; Spatz A; Laud K; Lenoir GM; Bressac-de-Paillerets B Genes Chromosomes Cancer; 2003 Nov; 38(3):265-8. PubMed ID: 14506702 [TBL] [Abstract][Full Text] [Related]
13. Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain. de Torre C; Garcia-Casado Z; Martínez-Escribano JA; Botella-Estrada R; Bañuls J; Oliver V; Mercader P; Azaña JM; Frias J; Nagore E Melanoma Res; 2010 Aug; 20(4):342-8. PubMed ID: 20539244 [TBL] [Abstract][Full Text] [Related]
14. Analysis of Latvian familial melanoma patients shows novel variants in the noncoding regions of CDKN2A and that the CDK4 mutation R24H is a founder mutation. Veinalde R; Ozola A; Azarjana K; Molven A; Akslen LA; Doniņa S; Proboka G; Cēma I; Baginskis A; Pjanova D Melanoma Res; 2013 Jun; 23(3):221-6. PubMed ID: 23546221 [TBL] [Abstract][Full Text] [Related]
15. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. Begg CB; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Mitra N; Busam K; From L; Berwick M; J Natl Cancer Inst; 2005 Oct; 97(20):1507-15. PubMed ID: 16234564 [TBL] [Abstract][Full Text] [Related]
16. CDKN2A mutations in multiple primary melanomas. Monzon J; Liu L; Brill H; Goldstein AM; Tucker MA; From L; McLaughlin J; Hogg D; Lassam NJ N Engl J Med; 1998 Mar; 338(13):879-87. PubMed ID: 9516223 [TBL] [Abstract][Full Text] [Related]
17. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis. Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796 [TBL] [Abstract][Full Text] [Related]
18. High prevalence of germline CDKN2A mutations in Slovenian cutaneous malignant melanoma families. Hocevar M; Avbelj M; Perić B; Zgajnar J; Besić N; Battelino T Croat Med J; 2006 Dec; 47(6):851-4. PubMed ID: 17167857 [TBL] [Abstract][Full Text] [Related]
19. The p.G23S CDKN2A founder mutation in high-risk melanoma families from Central Italy. Gensini F; Sestini R; Piazzini M; Vignoli M; Chiarugi A; Brandani P; Ghiorzo P; Salvini C; Borgognoni L; Palli D; Bianchi-Scarrà G; Carli P; Genuardi M Melanoma Res; 2007 Dec; 17(6):387-92. PubMed ID: 17992122 [TBL] [Abstract][Full Text] [Related]
20. New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment. Kannengiesser C; Dalle S; Leccia MT; Avril MF; Bonadona V; Chompret A; Lasset C; Leroux D; Thomas L; Lesueur F; Lenoir G; Sarasin A; Bressac-de Paillerets B Genes Chromosomes Cancer; 2007 Aug; 46(8):751-60. PubMed ID: 17492760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]